Targeting Human Thymidylate Kinase Induces DNA Repair Toxicity in Malignant Tumor Cells
申请人:Chang Zee-Fen
公开号:US20130252953A1
公开(公告)日:2013-09-26
The present invention relates to novel TMPK inhibitor compositions and their methods of use. In particular, it relates to novel TMPK inhibitor compositions and therapeutics that lead to dUTP-mediated DNA repair in tumor cells and acts as a novel chemosensitizer, which are useful in methods for treating or preventing cancers.
本发明涉及新型TMPK抑制剂组合物及其使用方法。具体而言,涉及新型TMPK抑制剂组合物和治疗方法,可导致dUTP介导的肿瘤细胞DNA修复,并作为新型化疗增敏剂,适用于治疗或预防癌症的方法。